Gerard Nuovo

8PUBLICATIONS
43CO-AUTHORS
Haematological tumoursMolecular targetsAutoimmunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 25, 2025
A Putative Role for the BCL2 Family of Proteins in the Pathophysiology of ALS.

Gerard J Nuovo, Candice Crilly, Anne Lietzke

|Feb 11, 2025
The Prevention of Fatal Tauopathy in a Mouse Model of Alzheimer Disease by Blocking BCL2.

Gerard J Nuovo, Madison Rice, Nicola Zanesi

|Dec 17, 2023
Comparison of Neuroinflammation Induced by Hyperphosphorylated Tau Protein Versus Ab42 in Alzheimer's Disease.

Madison Rice, Gerard J Nuovo, Dwitiya Sawant

|Oct 09, 2023
Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial.

Steffan T Nawrocki, Julian Olea, Claudia Villa Celi

|Mar 10, 2019
Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model.

Chandini M Thirukkumaran, Zhong Qiao Shi, Gerard J Nuovo

|Jan 05, 2018
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.

Adel Samson, Karen J Scott, David Taggart

Pageof 2